Boston Scientific (NYSE:BSX) announced that published results from an analysis of its SpaceOAR hydrogel spacer revealed safe prostate-rectum separation. Marlborough, Mass.-based Boston Scientific has developed the SpaceOAR since its $600 million acquisition of Augmenix in September 2018. The absorbable polyethylene glycol hydrogel spacer won CE Mark approval in the European Union in 2010 and 510(k) clearance from the […]
Accuray launches CyberKnife S7 system
Accuray (NSDQ:ARAY) announced today that it launched its CyberKnife S7 system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Using real-time artificial intelligence-driven motion tracking and synchronization, CyberKnife S7 offers treatments for SRS and SBRT in as little as 15 minutes, according to a news release. The system’s AI adapts radiation delivery to patient […]
RefleXion, Merck team up on late-stage cancer study
RefleXion announced today that it entered into a clinical collaboration with Merck to evaluate Merck’s (NYSE:MRK) Keytruda anti-PD-1 therapy in clinical trials. Hayward, Calif.-based therapeutic oncology company RefleXion is joining forces with Merck to evaluate Keytruda’s safety and efficacy in combination with RefleXion’s biology-guided radiotherapy (BgRT) in multiple late-stage cancers, including non-small cell lung cancer, in […]
AtomicBlue launches ultraviolet light device to decontaminate N95 masks
Atomic Blue announced today that it launched a UV-C germicidal light to eradicate the COVID-19 virus during equipment decontamination processes. Earlier this month, the National Institutes of Health validated four methods for mask decontamination, one of which was ultraviolet light. Atomic Blue said in a news release that the NIH tested its UV-C germicidal light, […]
Brainlab wins CE Mark for next-gen ExacTrac Dynamic system
Brainlab announced that it received CE Mark approval in Europe for its ExacTrac Dynamic next-generation patient positioning and monitoring system. ExacTrac Dynamic offers high-speed thermal surface tracking technology combined with updated ExacTrac X-ray monitoring designed to treat a wide variety of indications in what Brainlab touts as an “all-in-one” radiotherapy tracking system. Munich-based Brainlab’s system […]
RefleXion Medical raises $100m for biology-guided cancer radiotherapy
Therapeutic oncology company RefleXion Medical announced today that it closed an equity financing with proceeds of $100 million. Public Sector Pension Investment Board (PSP Investments), a large, Canada-based pension investment manager focused on long-term investments, led the funding, according to a news release. Existing investors TPG’s The Rise Fund, KCK Group, Sofinnova Partners, Venrock, T. […]
Could AI help monitor coronavirus disease progression?
Artificial intelligence radiology tech developer Qure.ai announced that it is working with the San Raffaele University Hospital in Milan to monitor disease progression in COVID-19 patients. The Mumbai-based company’s QXR automated chest X-ray system is designed to interpret a coronavirus patient’s lung scans within seconds, quantifying how much of their lungs have been affected by […]
How is the coronavirus affecting medtech events?
The coronavirus (COVID-19) outbreak has swept the globe and made a huge impact in the medtech space — especially when it comes to the events that provide a crucial networking and innovation-sharing function. The March 5 cancellation of the Healthcare Information and Management Systems Society (HIMSS) 2020 Global Health Conference & Exhibition was one of […]
RaySearch Labs issues urgent field safety notice for certain RayStations
RaySearch Laboratories issued an urgent field safety notice in Europe to warn on an issue with the dose calculation for the Siemens (NYSE:SI) virtual wedge in several of RaySearch’s RayStation treatment planning systems. The affected RayStation models listed in the safety notice out of Germany included RayStation 4.0, RayStation 4.5, RayStation 4.7, RayStation 4.9 (RayPlan 1), […]
FDA clears Varian’s AI-driven radiation therapy
Varian Medical Systems (NYSE:VAR) announced today that it won FDA 510(k) clearance for its Ethos AI-driven adaptive intelligence solution for cancer care. Ethos is designed to offer an adaptive treatment based on the patient’s anatomy and position to better target the tumor, reduce the dose to healthy tissue and improve overall outcomes within a 15-minute time […]
Varian Medical shares down on Q1 bottom-line slide
Varian Medical (NYSE:VAR) shares dropped today on first-quarter results that came up short of the consensus forecast. The Palo Alto, Calif.–based radiotherapy device maker posted profits of $88.9 million, or 96¢ per share, on sales of $829.9 million for the three months ended Dec. 31, 2019, for a 14.4% bottom-line slide on sales growth of 11.9%. […]
- 1
- 2
- 3
- …
- 17
- Next Page »
